Dergiler / Archives of Rheumatology / 2022 / Cilt: 37 - Sayı: 1

Serum progranulin levels in axial spondyloarthropathy and relationship with clinical features

Sayfa
110–118
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Serum PGRN levels were significantly higher in female patients in the patient group (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In this study, we aimed to investigate the serum progranulin (PGRN) levels in patients with axial spondyloarthropathy (AxSpA) and to identify the correlation between disease activity, symptom severity, acute phase reactant (APR), and serum PGNR levels in patients with AxSpA.
📊
Temel Bulgular & Veri:Patients and methods: This prospective, cross-sectional study included a total of 152 patients (105 males, 47 females; mean age: 41.8±10.3; range 20 to 65 years) with AxSpA according to the 2009 Assessment of SpondyloArthritis Society (ASAS) criteria who received treatment and 100 healthy individuals (61 males, 39 females; mean age 43.4±14.2; range 20 to 65 years) between February 2018 and February 2019.
💡
Sonuç & Katkı:Serum PGRN levels were significantly higher in female patients in the patient group (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: In this study, we aimed to investigate the serum progranulin (PGRN) levels in patients with axial spondyloarthropathy (AxSpA) and to identify the correlation between disease activity, symptom severity, acute phase reactant (APR), and serum PGNR levels in patients with AxSpA. Patients and methods: This prospective, cross-sectional study included a total of 152 patients (105 males, 47 females; mean age: 41.8±10.3; range 20 to 65 years) with AxSpA according to the 2009 Assessment of SpondyloArthritis Society (ASAS) criteria who received treatment and 100 healthy individuals (61 males, 39 females; mean age 43.4±14.2; range 20 to 65 years) between February 2018 and February 2019. Serum PGRN levels from the venous blood were analyzed in both groups. The clinical AxSpA assessment scales were used in the patient group. Erythrocyte sedimentation rate and C-reactive protein levels were examined. Results: The mean serum PGRN level was 6.9±5.4 ng/mL in the patient group and 11.2±6.0 ng/mL in the control group. Serum PGRN level was significantly higher in the control group (p0.05). Serum PGRN levels were significantly higher in female patients in the patient group (p

🔖

Bu Makaleye Atıf Yap

AKSOY, M. K., ALTAN, L., DOĞANGÜN, D. İ. (2022). Serum progranulin levels in axial spondyloarthropathy and relationship with clinical features. Archives of Rheumatology, Cilt: 37 - Sayı: 1, 110–118. https://ajindex.com/articles/447950

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Gran JT, Husby G. HLA-B27 and spondyloarthropathy: Value for early diagnosis? J Med Genet 1995;32:497- 501
  2. Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: A literature review. J Rheumatol 1999;26:966-70
  3. Claushuis TA, de Vries MK, van der Weijden MA, Visman IM, Nurmohamed MT, Twisk JW, et al. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis. Clin Exp Rheumatol 2015;33:159-65
  4. Thurner L, Fadle N, Regitz E, Kemele M, Klemm P, Zaks M, et al. The molecular basis for development of proinflammatory autoantibodies to progranulin. J Autoimmun 2015;61:17-28
  5. Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 2008;118:2438-47
  6. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011;332:478-84
  7. Kojima Y, Ono K, Inoue K, Takagi Y, Kikuta K, Nishimura M, et al. Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis 2009;206:102-8
  8. Yanik B, Gürsel YK, Kutlay S, Ay S, Elhan AH. Adaptation of the bath ankylosing spondylitis functional index to the Turkish population, its reliability and validity: Functional assessment in AS. Clin Rheumatol 2005;24:41-7
  9. Huang K, Chen A, Zhang X, Song Z, Xu H, Cao J, et al. Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation. Immunology 2015;145:279-87
  10. Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M, et al. Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. Arthritis Res Ther 2015;17:27
  11. Zhao YP, Tian QY, Liu CJ. Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice. FEBS Lett 2013;587:1805-10
  12. Cerezo LA, Kuklová M, Hulejová H, Vernerová Z, Kaspříková N, Veigl D, et al. Progranulin is associated with disease activity in patients with rheumatoid arthritis. Mediators Inflamm 2015;2015:740357
  13. Johnson J, Yeter K, Rajbhandary R, Neal R, Tian Q, Jian J, et al. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with T